E. Bolaños

发表

Cyclophosphamide for Metastatic Cancer Combined with GM-CSF, Pegylated IFN, and Loaded with Autologous Tumor Lysates Pilot Clinical Trial of Type 1 Dendritic Cells

B. Sangro, I. Melero, S. Martín-Algarra, 2011 .

Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients

B. Sangro, I. Melero, S. Martín-Algarra, 2011, The Journal of Immunology.

Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy

I. Melero, M. Rodriguez-Ruiz, V. Lang, 2016, European journal of immunology.

Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic

O. Vasiljeva, M. Belvin, I. Melero, 2021, Proceedings of the National Academy of Sciences.

Novel strategies exploiting interleukin-12 in cancer immunotherapy.

I. Melero, P. Berraondo, E. Castañón, 2022, Pharmacology & therapeutics.

Synergistic effects of CTLA‐4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo

B. Sangro, I. Melero, S. Martín-Algarra, 2011, International journal of cancer.

Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage?

P. Friedl, I. Melero, M. Rodriguez-Ruiz, 2016, Cancer Immunology, Immunotherapy.

Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)

J. Zapata, I. Melero, M. Rodriguez-Ruiz, 2018, Oncoimmunology.

TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies

I. Melero, M. Rodriguez-Ruiz, J. Pérez-Gracia, 2019, Molecular Cancer Therapeutics.

Virotherapy with a Semliki Forest Virus–Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade

I. Melero, V. Segura, E. Bolaños, 2015, Cancer Immunology Research.

Combined Immunostimulatory Monoclonal Antibodies Extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model

B. Sangro, I. Melero, S. Hervás-Stubbs, 2013, Clinical Cancer Research.

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.

K. Schalper, I. Melero, M. Rodriguez-Ruiz, 2016, Cancer research.

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming.

S. Quezada, I. Melero, M. Rodriguez-Ruiz, 2018, Cancer research.

Exploiting TCR Recognition of Shared Hotspot Oncogene-encoded Neoantigens

I. Melero, E. Bolaños, I. Etxeberría, 2020, Clinical Cancer Research.

Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb

I. Melero, A. Anel, S. Hervás-Stubbs, 2013, Journal of Immunotherapy for Cancer.

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism

I. Melero, M. Rodriguez-Ruiz, J. Pérez-Gracia, 2014, Journal of Immunotherapy for Cancer.

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb

P. Friedl, Lieping Chen, I. Melero, 2015, Proceedings of the National Academy of Sciences.

Cellular cytotoxicity is a form of immunogenic cell death

I. Melero, M. Rodriguez-Ruiz, P. Berraondo, 2020, Journal for ImmunoTherapy of Cancer.

Abstract 1691: CD137 (4-1BB) costimulation of CD8 T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation

M. Rodriguez-Ruiz, P. Berraondo, M. Sanmamed, 2021, Immunology.

Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation

I. Melero, D. Sancho, Á. Teijeira, 2018, Cancer Immunology Research.

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

I. Melero, M. Rodriguez-Ruiz, P. López-Casas, 2019, Journal of Immunotherapy for Cancer.

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes

F. Sánchez‐Madrid, I. Melero, P. Maiso, 2017, Oncoimmunology.

Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells.

I. Melero, A. Villanueva, X. Matías-Guiu, 2019, Cancer cell.